• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

OTB Ventures

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

    Plumerai secures £6.5m Series A led by Partech and OTB Ventures to scale vision LLMs for edge devicesPlumerai secures £6.5m Series A led by Partech and OTB Ventures to scale vision LLMs for edge devices
    Plumerai
    16 Sept 2025

    Plumerai secures £6.5m Series A led by Partech and OTB Ventures to scale vision LLMs for edge devices

    Plumerai builds on-device computer vision software for cameras, combining edge AI with cloud models to deliver accurate detection, search and alerts while keeping costs and data usage low.

    Safe Intelligence raises £4m seed round led by Amadeus Capital to conduct deep validation of AI modelsSafe Intelligence raises £4m seed round led by Amadeus Capital to conduct deep validation of AI models
    Safe Intelligence
    20 Feb 2025

    Safe Intelligence raises £4m seed round led by Amadeus Capital to conduct deep validation of AI models

    Safe Intelligence builds tools for deep validation of AI models, identifying hidden fragilities and improving robustness so complex systems behave reliably in regulated and safety-critical environments.

OTB Ventures
    • AI
  • 1(12 months)
  • otb.vc
  • Update Information

More venture news

  • Capsa AI lands £14m Series A led by TX Ventures and Pivot Investment Partners to build the AI operating system for private capital
    Capsa AI
    10 Jun 2026

    Capsa AI lands £14m Series A led by TX Ventures and Pivot Investment Partners to build the AI operating system for private capital

    Series AAI
  • NewOrbit raises £14m in a Series A led by Voyager Ventures to build the first commercial satellites for very low Earth orbit
    NewOrbit
    9 Jun 2026

    NewOrbit raises £14m in a Series A led by Voyager Ventures to build the first commercial satellites for very low Earth orbit

    Series ADeep Tech
  •  IMU Biosciences unlocks £40m Series A led by IQ Capital and Molten Ventures to decode the immune system with high-resolution blood analysis
    IMU Biosciences
    2 Jun 2026

    IMU Biosciences unlocks £40m Series A led by IQ Capital and Molten Ventures to decode the immune system with high-resolution blood analysis

    Series ALife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn